Hypercalcemia is a well-known post-HSCT complication in ARO,16–19 but in the RANK-dependent patients here reported, it seems to have a higher prevalence and a longer persistence, requiring more aggressive treatments. The gene discussed is TNFRSF11A; the disease is hypercalcemia disease.